Is it just me, or is the market that CYC is targeting super small?
"Cyclopharm is initially targeting the 600,000 nuclear medicine imaging procedures for PE, a marketwhich it estimates to be approximately US$90 million per annum. Based on Cyclopharm’s experiencein the Canadian market and globally, the company reiterates expectations it can achieve a 50% shareof this market over the next 2 to 3 years, rising to in excess of an 80% share over a 3 to 5-year period."
Ann: Cyclopharm Receives USFDA Approval for Technegas, page-14
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.050(3.13%) |
Mkt cap ! $172.2M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $13.25K | 8.366K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 539 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 2806 | 1 |
View Market Depth
| Last trade - 15.59pm 24/07/2024 (20 minute delay) ? |
| CYC (ASX) Chart |